1,304
Views
382
CrossRef citations to date
0
Altmetric
Review Article

Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin

, , &
Pages 175-200 | Received 05 May 2009, Accepted 15 May 2009, Published online: 06 Jul 2009

References

  • Abdel-Wahab MH, Akoul EMS and Abdel-Aziz AH. 2000. Modulatory effects of melatonin and vitamin E in doxorubicin-induced cardiotoxicity in Ehrlich ascites carcinoma-bearing mice. Tumori 86:157–162.
  • Abe M, Reiter RJ, Orhii P, Hara M and Poeggeler B. 1994. Inhibitory effects of melatonin on cataract formation in newborn rats: evidence for an antioxidative role for melatonin. J Pineal Res 17:94–100.
  • Abe M, Itoh MT, Miyata M, Ishikawa S and Sumi Y. 1999. Detection of melatonin, its precursors and related enzyme activities in rabbit lens. Exp Eye Res 68:255–262.
  • Abecia JA, Forcada F and Zuniga O. 2002. The effect of melatonin on the secretion of progesterone in sheep and on the development of ovine embryos in vitro. Vet Res Commun 26:151–158.
  • Acuna-Castroviejo D, Reiter RJ, Menendez-Pelaez A, Pablos MI and Burgos A. 1994. Characterization of high affinity melatonin binding sites in purified cell nuclei of rat liver. J Pineal Res 16: 100–112.
  • Albarran MT, Lopez-Burrillo S, Pablos MI, Reiter RJ and Agapito MT. 2001. Endogenous rhythms of melatonin, total antioxidant status and superoxide dismutase activity in several tissues of chick and their inhibition by light. J Pineal Res 30:227–233.
  • Allegra M, Reiter RJ, Tan DX, Gentile C, Tesoriere L and Livrea MA. 2003. The chemistry of melatonin interaction with reactive species. J Pineal Res 34:1–10.
  • Antolin I, Obst B, Burkhardt S and Hardeland R. 1997. Antioxidative protection in a high-melatonin organism: the dinoflagellate Gonyaulax polyedra is rescued from lethal oxidative stress by strongly elevated, but physiologically possible concentrations of melatonin. J Pineal Res 23:182–190.
  • Antunes F, Barclay LR, Ingold KU, King M, Norris JQ, Scaiano JC and Xi F 1999. On the antioxidant activity of melatonin. Free Radic Biol Med 26:117–128.
  • Arendt J. 1997. Safety of melatonin in long-term use (?). J Biol Rhythms 12:673–681.
  • Arendt J. 2005. Melatonin as a chronobiotic. Sleep Med Rev 9:25–39.
  • Axelrod J, Wurtman RJ and Winget CM. 1964. Melatonin synthesis in the hen pineal gland and its control by light. Nature 201:1134.
  • Axelrod J, Wurtman RJ and Snyder SH. 1965. Control of hydroxyindole-O-methyltransferase activity in the rat pineal gland by environmental lightening. J Biol Chem 240:949–954.
  • Bandyopadhyay D, Biswas K, Bandyopadhyay U, Reiter RJ and Banerjee RK. 2000. Melatonin protects against stress-induced gastric lesions by scavenging hydroxyl radicals. J Pineal Res 29:143–151.
  • Barlow-Walden LR, Reiter RJ, Abe M, Pablos MI, Menedez-Pelaez A, Chen LD and Poeggeler B. 1995. Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int 26:497–502.
  • Barrett P, Conway S and Morgan PJ. 2003. Digging deep – structure-function relationships in the melatonin receptor family. J Pineal Res 35:3221–3230.
  • Baydas G, Canatan H and Turkoglu A. 2002a. Comparative analysis of the protective effects of melatonin and vitamin E on streptozotocin-induced diabetes mellitus. J Pineal Res 32:225–230.
  • Baydas G, Gursu MF, Yilmaz S, Canpolat S, Yasar A, Cikim G and Canatan H. 2002b. Daily rhythm of glutathione peroxidase activity, lipid peroxidation and glutathione levels in tissues of pinealectomized rats. Neurosci Lett 323:195–198.
  • Beckman JS and Koppenol WH. 1996. Nitric oxide, superoxide, and peroxynitrite: The good, the bad and the ugly. Am J Physiol 271:C1424–C1437.
  • Benitez-King G. 2006. Melatonin as a cytoskeletal modulator: implications for cell physiology and disease. J Pineal Res 40:1–9.
  • Bertrand S, Faivre B and Sorci G. 2006. Do carotenoid-based sexual traits signal the availability of non-pigmentary antioxidants? J Exp Biol 209:4414–4419.
  • Bjorneboe A, Bjorneboe GA and Drevon CA. 1990. Absorption, transport and distribution of vitamin E. J Nutr 120:233–242.
  • Blanchard B, Pompon D and Ducrocq C. 2000. Nitrosation of melatonin by nitric oxide and peroxynitrite. J Pineal Res 29:184–192.
  • Blask DE, Dauchy RT and Sauer LA. 2005. Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal. Endocrine 27:179–188.
  • Blickenstaff RT, Brandstadter SM, Reddy S and Witt R. 1994. Potential radioprotective agents. 1. Homologs of melatonin. J Pharm Sci 83:216–218.
  • Brizel DM. 2007. Pharmacologic approaches to radiation protection. J Clin Oncol 25:4084–4089.
  • Brömme HJ, Mörke W, Peschke E, Ebelt H and Peschke D. 2000. Scavenging effect of melatonin on hydroxyl radicals generated by alloxan. J Pineal Res 29:201–208.
  • Bubenik GA. 2002. Gastrointestinal melatonin: localization, function and clinical relevance. Dig Dis Sci 47:2336–2348.
  • Bubenik GA, Hacker RR, Brown GM and Bartos L. 1999. Melatonin concentrations in the luminal fluid, mucosa, and muscularis of the bovine and porcine gastrointestinal tract. J Pineal Res 26:56–63.
  • Cadenas S and Barja G. 1999. Resveratrol, melatonin, vitamin E, and PBN protect against renal oxidative damage induced by the kidney carcinogen KBrO3. Free Radic Biol Med 26:1531–1537.
  • Cahill GM and Besharse JC. 1992. Light sensitive melatonin synthesis by Xenopus photoreceptors after destruction of the inner retina. Vis Neurosci 8:487–490.
  • Cardinali DP, Esquifino AI, Srinivasan V and Pandi-Perumal SP. 2008. Melatonin and the immune system in aging. Neuroimmunomodulation 15:272–278.
  • Ceraulo L, Ferrugia M, Tesoriere L, Segreto S, Livera MA and Turco Liveri V. 1999. Interactions of melatonin with membrane models: portioning of melatonin in AOT and lecithin reversed micelles. J Pineal Res 26:108–112.
  • Cerutti PA. 1994. Oxy-radicals and cancer. Lancet 344:862–863.
  • Chang HM, Huang YL, Lan CT, Wu UI, Hu ME and Youn SC. 2008. Melatonin preserves superoxide dismutase activity in hypoglossal motoneurons of adult rats following peripheral nerve injury. J Pineal Res 44:172–180.
  • Chen Z, Chua CC, Gao J, Chau KW, Ho HS, Hamdy RC and Chau BHL. 2009. Prevention of ischemia/reperfusion-induced cardiac apoptosis and injury by melatonin is independent of glutathione peroxidase 1. J Pineal Res 46:235–241.
  • Cheung RTF. 2003. Oxidative damage in the central nervous system: protection by melatonin. Progr Neurobiol 56:359–384.
  • Clapp-Lilly KL, Smith MA, Perry G, Harris PL, Zhu X and Duffy LK. 2001. Melatonin acts as a pro-oxidant in an organotypic slice culture model of Alzheimer’s disease. Neuroreport 12:1277–1280.
  • Clark IA, Chaudhri G and Cowden WB. 1989. Some roles of free radicals in malaria. Free Radic Biol Med 6:315–321.
  • Conti A, Conconi S, Hertens E, Skwarlo-Sonta KI, Markowska M and Maestroni GJM. 2000. Evidence for melatonin synthesis in mouse and human bone marrow. J Pineal Res 28:193–204.
  • Cuzzocrea S and Reiter RJ. 2001. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury. Eur J Pharmacol 426:1–10.
  • de Almeida EA, Martinez GR, Klitzke CF, de Medeiros MH and Di Mascio P. 2003. Oxidation of melatonin by singlet oxygen (O2 (1 delta g)) produces N1-acetyl-N2-formyl-5-methoxykynuramine. J Pineal Res 35:131–137.
  • Dey S, Guha M, Alan A, Goyal M, Binder S, Pal C, Maity P, Mitra K and Bandyopadhyay U. 2009. Malarial infection develops mitochondrial pathology and mitochondrial oxidative stress to promote hepatocyte apoptosis. Free Radic Biol Med 46:271–281.
  • Dobsak P, Siegelova J, Eicher JC, Jancik J, Svacinova H, Vasku J, Kuchtickova S, Horky M and Wolf JE. 2003. Melatonin protects against ischemia-reperfusion injury and inhibits apoptosis in isolated working rat heart. Pathophysiology 9:179–187.
  • Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Kashi JC, Reiter RJ and Jimenez-Sosa A. 2007. A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of Melatonin as an Adjunct in patients with acute myocaRdial Infarction undergoing Angioplasty. The Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial: study design and rationale. Contemp Clin Trials 28:532–539.
  • Dominguez-Rodriguez A, Abreu-Gonzalez P, Garcia-Gonzalez MJ, Samimi-Fard S, Kashi JC and Reiter RJ. 2008. Light/dark patterns of soluble vascular cell adhesion molecule-1 in relation to melatonin in patients with ST-segment elevation myocardial infarction. J Pineal Res 44:65–69.
  • Dubocovich ML and Markowska M. 2005. Functional MT1 and MT2 melatonin receptors in mammals. Endocrine 27:101–110.
  • Ebelt H, Peschke D, Brömme HJ, Mörke W, Blume R and Peschke E. 2000. Influence of melatonin on free radical-induced changes in rat pancreatic beta-cells in vitro. J Pineal Res 28:65–72.
  • El-Sokkary GH, Reiter RJ, Cuzzocrea S, Caputi AP, Hassanein HF and Tan DX. 1999. Role of melatonin in the reduction of lipid peroxidation and peroxynitrite formation in non-specific shock induced by zymosan. Shock 12:402–408.
  • Escames G, Guerrero JM, Reiter RJ, Garcia JJ, Munoz-Hoyos A, Ortiz GG and Oh CS. 1997. Melatonin and vitamin E limit nitric oxide-induced lipid peroxidation in rat brain homogenates. Neurosci Lett 230:147–150.
  • Esposito E, Iacono A, Muia C, Crisafulli C, Mattace Raso G, Bramanti P, Meli R and Cuzzocrea S. 2008. Signal transduction pathways involved in protective effects of melatonin in C6 glioma cells. J Pineal Res 44:78–87.
  • Esrefoglu M, Gül M, Ates B, Batcioglu K and Selimoglu MA. 2006. Antioxidant effect of melatonin, ascorbic acid and N-acetylcysteine on caerulein-induced pancreatitis and associated liver injury in rats. World J Gastroenterol 14:259–264.
  • Fischer TW, Sweatman TW, Semak I, Sayre RM, Wortsman J and Slominski A. 2006. Constitutive and UV-induced metabolism of melatonin in keratinocytes and cell-free systems. FASEB J 20:1564–1566.
  • Fischer TW, Slominski A, Zmijewski MA, Reiter RJ and Paus R. 2008. Melatonin as a major skin protectant: from free radical scavenging to DNA damage repair. Exp Dermatol 17:713–730.
  • Fowler G, Daroszewska M and Ingold KU. 2003. Melatonin does not “directly scavenge hydrogen peroxide”: demise of another myth. Free Radic Biol Med 34:77–83.
  • Fuhrberg B, Hardeland R, Poeggeler B and Behrmann G. 1997. Dramatic rises of melatonn and 5-methoxyyptamine in Gonyaulax exposed to decreased temperature. Biol Rhythm Res 28:144–150.
  • Fukutomi J, Fukuda A, Fukuda S, Hara M, Terada A and Yoshida M. 2006. Scavenging activity of indole compounds against ciplatin-induced reactive oxygen species. Life Sci 80:254–257.
  • Fulia F, Gitto E, Cuzzocrea S, Reiter RJ, Dugo L, Gitto P, Barberi S, Cardano S and Barberi I. 2001. Increased levels of malondialdehyde and nitrite/nitrate in the blood of asphyxiated newborns: reduction by melatonin. J Pineal Res 31:343–349.
  • Gilad E, Cuzzocrea S, Zingarella B, Salzman AL and Szabo C. 1997. Melatonin is a scavenger of peroxynitrite. Life Sci 60:PL169–PL174.
  • Gitto E, Reiter RJ, Karbownik M, Tan DX and Barberi I. 2001a. Respiratory distress syndrome in the newborn: role of oxidative stress. Inten Care Med 27:1116–1123.
  • Gitto E, Karbownik M, Reiter RJ, Dugo L, Gitto P, Barberi S, Cardaro S and Barberi I. 2001b. Effects of melatonin treatment in septic newborns. Pediatr Res 50:756–760.
  • Gitto E, Reiter RJ, Karbownik M, Tan DX, Gitto P, Barberi S, Barberi I. 2002. Causes of oxidative stress in the pre- and perinatal period. Biol Neonate 81:146–157.
  • Gitto E, Reiter RJ, Cardaro SP, La Rosa M, Chiurazzi P, Trimarchi G, Gitto P, Calabro MP and Barberi I. 2004a. Oxidative and inflammatory parameters in respiratory distress syndrome of preterm newborns: beneficial effects of melatonin. Am J Perinatol 21:209–216.
  • Gitto E, Romeo C, Reiter RJ, Impellizzeri P, Pesce S, Basile M, Antonuccio P, Trimarchi G, Gentile C, and Barberi I. 2004b. Melatonin reduces oxidative stress in surgically-treated newborns. J Pediatr Res 39:184–189.
  • Gitto E, Pellegrino S, Gitto P, Barberi I and Reiter RJ. 2009. Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. J Pineal Res 46:128–139.
  • Giusti P, Franceschini D, Petrone M, Manev H and Floreani M. 1996. In vitro and in vivo protection against kainate-induced excitotoxicity by melatonin. J Pineal Res 20:226–231.
  • Gorfine T and Zisapil N. 2009. Late evening brain activation patterns and their relation to the internal biological time, melatonin, and homeostatic sleep debt. Human Brain Mapp 30:541–552.
  • Guardiola-Le Maitre B. 1997. Toxicology of melatonin. J Biol Rhythms 12:697–706.
  • Guenther AL, Schmidt SI, Laatsch H, Fotso S, Ness H, Ressmeyer AR, Poeggeler B and Hardeland R. 2005. Reactions of melatonin metabolite AMK (N1-acetyl-5-methoxykynuramine) with reactive nitrogen species: formation of novel compounds, 3-acetamidomethyl-5-methoxycinnolinone and 3-nitro-AMK. J Pineal Res 39:251–260.
  • Guha M, Kumar S, Choubey V, Maity P and Bandyopadhyay U. 2006. Apoptosis in liver during malaria: role of oxidative stress and implication of mitochondrial pathway. FASEB J 20:1224–1226.
  • Guha M, Marty P, Choubey V, Mitra K, Reiter RJ and Bandyopadhyay U. 2007. Melatonin inhibits free radical-mediated mitochondrial-dependent hepatocyte apoptosis and liver damage induced during malarial infection. J Pineal Res 43:372–381.
  • Gultekin F, Delibas N, Yasar S and Kilinc I. 2001. In vivo changes in antioxidant systems and the protective role of melatonin and a combination of vitamin C and vitamin E on oxidative damage in erythrocytes induced by chlorpyrifos-ethyl in rats. Arch Toxicol 75:88–96.
  • Halliwell B. 1997. Antioxidants and human disease: a general introduction. Nutr Rev 55:S44–S49.
  • Halliwell B. 2009. The wanderings of a free radical. Free Radic Biol Med 46:531–542.
  • Hardeland R. 2008. Melatonin, hormone of darkness and more: occurrence, control mechanisms, actions and bioactive substances. Cell Mol Life Sci 65:2001–2018.
  • Hardeland R and Pandi-Perumal SR. 2005. Melatonin, a potent agent in antioxidative defense: actions as a natural food constituent, gastrointestinal factor, drug and prodrug. Nutr Metab 2:22–37.
  • Hardeland R and Poeggeler B. 2003. Non-vertebrate melatonin. J Pineal Res 34:233–241.
  • Hardeland R, Reiter RJ, Poeggeler B and Tan DX. 1993. The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances. Neurosci Biobehav Rev 17:347–357.
  • Hardeland R, Balzer I, Poeggeler B, Fuhrberg B, Uria H, Behrmann G, Wolf R, Meyer TJ and Reiter RJ. 1995. On the primary functions of melatonin in evolution: mediation of photoperiodic signals in a unicell, photooxidation, and scavenging of free radicals. J Pineal Res 18:104–111.
  • Hardeland R, Poeggeler B, Niebergall R and Zelasko V. 2003. Oxidation of melatonin by carbonate radicals and chemiluminescence emitted during pyrrole ring cleavage. J Pineal Res 34:17–25.
  • Hardeland R, Pandi-Perumal SR and Cardinali DP. 2006. Melatonin. Int J Biochem Cell Biol 38:313–316.
  • Hevia D, Sainz RM, Blanca D, Quiros I, Tan DX, Rodriguez C, and Mayo JC. 2008. Melatonin uptake in prostate cancer cells: intracellular transport versus simple passive diffusion. J Pineal Res 45:247–257.
  • Hirata F, Hayaiski O, Tokuyama T and Seno SJ. 1974. In vitro and in vivo formation of two new metabolites of melatonin. J Biol Chem 249:1311–1313.
  • Hoffman RA and Reiter RJ. 1965a. Pineal gland: influence on gonads of male hamsters. Science 148:1609–1611.
  • Hoffman RA and Reiter RJ. 1965b. Influence of compensatory mechanisms and the pineal gland upon light-induced gonadal atrophy in male hamsters. Nature 207:658–659.
  • Hong RT, Xu JM and Mei Q. 2009. Melatonin ameliorates hepatic fibrosis induced by carbon tetrachloride in rats. World J Gastroenterol 15:1452–1458.
  • Hosseinimehr SJ. 2007. Trends in the development of radioprotective agents. Drug Discov Today 12:794–805.
  • Ishizuka B, Kuribayashi Y, Murai K, Amemiya A and Itoh MT. 2000. The effect of melatonin on in vitro fertilization and embryo development. J Pineal Res 28:48–51.
  • Itoh MP, Ishizuka B, Kuribayashi Y, Amemiya A and Sumi Y. 1999. Melatonin, its precursors, and synthesizing enzymes in the human ovary. Mol Human Reprod 5:402–408.
  • Itoh MT, Takahashi N, Abe M and Shimizu K. 2007. Expression and cellular localization of melatonin-synthesizing enzymes in the rat lens. J Pineal Res 42:92–96.
  • Jahnke G, Marr M, Myers C, Wilson R, Travalos G and Price C. 1999. Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicol Sci 50:271–279.
  • Jan JE, Wasdell MB, Freeman RD and Bax M. 2007. Evidence supporting the use of melatonin in short gestation infants. J Pineal Res 42:22–27.
  • Jan JE, Reiter RJ, Wasdell MB and Bax M. 2009. The role of thalamus in sleep, pineal melatonin production, and circadian rhythm sleep disorders. J Pineal Res 46:1–7.
  • Jou MJ, Jou SB, Chen HM, Lin CH and Peng TI. 2002. Critical role of mitochondrial reactive oxygen species formation in visible laser irradiation-induced apoptosis in rat brain astrocytes (RBA-1). J Biomed Sci 9:507–518.
  • Jou MJ, Peng TI, Reiter RJ, Jou SB, Wu HY and Wen ST. 2004. Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress induced apoptosis of rat brain astrocytes. J Pineal Res 37:55–70.
  • Jou MJ, Peng TI, Yu PZ, Jou SB, Reiter RJ, Chen JY, Wu HY, Chen CC and Hsu LF. 2007. Melatonin protects against common deletion of mitochondrial DNA-augmented mitochondrial oxidative stress and apoptosis. J Pineal Res 43:389–403.
  • Kaneko S, Okumura K, Numaguchi Y, Matsiu H, Murase K, Mokuno S, Morishima I, Hira K, Toki Y, Ito T, and Hayakawa T. 2000. Melatonin scavenges hydroxyl radical and protects isolated rat hearts from ischemic reperfusion injury. Life Sci 67:101–112.
  • Kara H, Cevik A, Konar V, Dayangac A and Servi K. 2008. Effect of selenium with vitamin E and melatonin on cadmuin-induced oxidative damage in rat liver and kidneys. Biol Trace Elem Res 125:236–244.
  • Karbownik M and Reiter RJ. 2000. Antioxidative effects of melatonin in protection against cellular damage caused by ionizing radiation. Proc Soc Exp Biol Med 225:9–22.
  • Karbownik M, Reiter RJ, Qi W, Garcia JJ, Tan DX, Manchester LC, and Vijayalaxmi 2000. Protective effects of melatonin against oxidation of guanine bases in DNA and deceased microsomal membrane fluidity in rat liver induced by whole body ionizing radiation. Mol Cell Biochem 211:137–144.
  • Khansari N, Shakiba Y and Mahmoudi M. 2009. Chronic inflammation and oxidative stress as a major cause of age-related diseases and cancer. Rec Patents Inflamm Allergy Drug Discov 3:73–80.
  • King TS and Steinlechner S. 1985. Pineal indolalkylamine synthesis and metabolism: kinetic considerations. Pineal Res Rev 3:69–114.
  • Kitay JI and Altschule MD. 1954. The Pineal Gland. Cambridge, MA: Harvard University Press.
  • Koh PO. 2008. Melatonin attenuates the focal ischemia injury by inhibiting the dissociation of pBad from 14-3-3. J Pineal Res 44:101–106.
  • Koppisetti S, Jenigiri B, Terron MP, Tengattini S, Tamura H, Flores LJ, Tan DX and Reiter RJ. 2008. Reactive oxygen species and the hypomobility of the gallbladder as targets for the treatment of gallstones with melatonin: a review. Dig Dis Sci 53:2592–2603.
  • Korkmaz A, Topal T, Oter S, Tan DX and Reiter RJ. 2008. Hyperglycemia-related pathophysiologic mechanisms and potential beneficial actions of melatonin. Mini-Rev Med Chem 8:1144–1153.
  • Korkmaz A, Sanchez-Barcelo E, Tan DX and Reiter RJ. 2009a. Role of melatonin in the epigenetic regulation of breast cancer. Breast Cancer Res Treat, 115:13–27.
  • Korkmaz A, Reiter RJ, Topal T, Manchester LC, Oter S and Tan DX. 2009b. Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med 15:43–50.
  • Kouvaris JR, Kouloulias VL and Vlahos LJ. 2007. Amifostine: the first selective-target and broad-spectrum radioprotector. Oncologist 12:738–747.
  • Kucukakin B, Lykkesfeldt J, Nielsen JJ, Reiter RJ, Rosenburg J and Gogenur I. 2008. Utility of melatonin to treat surgical stress after major vascular surgery – a safety study. J Pineal Res 44:426–431.
  • Kurokawa Y, Hayashi Y, Mackawa A, Takahashi M, Kokubo T and Odashima S. 1983. Carcinogenicity of potassium bromate administered orally to F344 rats. J Natl Cancer Inst 71:965–972.
  • Kvetnoy I. 2002. Extrapineal melatonin in pathology: new perspectives for diagnosis, prognosis and treatment of illness. Neuroendocr Lett 23 (suppl. 1):92–96.
  • Lagneux C, Joyeux M, Demenge P, Ribuot C and Godin-Ribuot D. 2000. Protective effects of melatonin against ischemia-reperfusion injury in the isolated rat heart. Life Sci 66:603–609.
  • Lee YM, Chen HR, Hsaao G, Shou JR, Wang JJ and Yen MH. 2002. Protective effects of melatonin on myocardial ischemia/reperfusion injury in vivo. J Pineal Res 33:72–80.
  • Leon J, Acuna-Castroviejo D, Saenz RM, Mayo JC, Tan DX and Reiter RJ. 2004. Melatonin and mitochondrial function. Life Sci 75:765–790.
  • Leon J, Acuna-Castroviejo D, Escames G, Tan DX and Reiter RJ. 2005. Melatonin mitigates mitochondrial malfunction. J Pineal Res 38:1–9.
  • Leon J, Escames G, Rodriguez MI, Lopez LC, Tapias V, Enterna A, Camacho E, Carrion MD, Gallo MA, Espinosa A, Tan DX, Reiter RJ, and Acuna-Castroviejo D. 2006. Inhibition of neuronal nitric oxide synthase activity by N1-acetyl-5-methoxykynuramine, a brain metabolite of melatonin. J Neurochem 98:2023–2033.
  • Lerner AB and Wright RM. 1960. In vitro frog skin assay for agents that darken and lighten melanocytes. Meth Biochem Anal 8:295–307.
  • Lerner AB, Case JD, Takahashi Y, Lee Y and Mori W. 1958. Isolation of melatonin, the pineal gland factor that lightens melanocytes. J Amer Chem Soc 80:2587.
  • Lerner AB, Case JD and Heinzelmann RV. 1959a. Structure of melatonin. J Amer Chem Soc 81:6084–6085.
  • Lerner AB, Case JD, Mori W and Wright MR. 1959b. Melatonin in peripheral nerve. Nature 27:1826.
  • Lerner AB, Case JD and Takahashi Y. 1960. Isolation of melatonin and 5-methoxyindole-3-acetic acid from bovine pineal gland. J Biol Chem 235:1992–1997.
  • Li XJ, Gu J, Lu SD and Sun FY. 2002. Melatonin attenuates MPTP-induced dopaminergic neuronal injury associated with scavenging hydroxyl radicals. J Pineal Res 32:47–52.
  • Li ZR, Reiter RJ, Fujimori O, Ho CS and Duan YP. 1997. Cataractogenesis and lipid peroxidation in newborn rats treated with buthionine-sulfoximine: prevented actions of melatonin. J Pineal Res 22:117–123.
  • Liepnitz G, Solano AF, Seminotti B, Amaral AU, Fernandes CG, Beskow AP, Dutro Filho CS and Weiner M. 2009. Glycine provokes lipid oxidative damage and reduces the antioxidant defenses in brain cortex of young rats. Cell Mol Neurobiol 29:253–261.
  • Lincoln GA, Andersonn H and Loudon A. 2003. Clock genes in calendar cells as the basis of annual timekeeping in mammals – a unifying hypothesis. J Endocrinol 79:1–13.
  • Livrea MA, Tesoriere L, D’Arpa D and Morreale M. 1997. Reaction of melatonin with hydroxyl radicals in phospholipid bilayers. Free Radic Biol Med 5:706–711.
  • Lopez-Burillo S, Tan DX, Mayo JC, Sainz RM, Manchester LC and Reiter RJ. 2003. Melatonin, xanthurenic acid, resveratrol, EGCG, vitamin C and alpha-lipoic acid differentially reduce oxidative DNA damage induced by Fenton reagents: a study of their individual and synergistic actions. J Pineal Res 34:269–277.
  • Ma X, Idle JR, Krauez KW, Tan DX, Ceraulo L and Gonzalez FJ. 2006. Urinary metabolites and antioxidant products of exogenous melatonin in the mouse. J Pineal Res 40:343–349.
  • Mahal HS, Sharma HS and Mukerjee T. 1999. Antioxidant properties of melatonin: a pulse radiolysis study. Free Radic Biol Med 26:557–565.
  • Maldonado MD, Murrillo-Cabezas F, Calvo JR, Lardone PJ, Tan DX, Guerrero JM and Reiter RJ. 2007. Melatonin as pharmacologic support in burn patients: a proposed solution to thermal injury-related lymphocytopenia and oxidative damage. Crit. Care Med. 35:1177–1185.
  • Maldonado MD, Perez-San-Gregorio MA and Reiter RJ. 2009. The role of melatonin in the immune-neuro-psychology of mental disorders. Rec Patents CNS Drug Disc 4:61–69.
  • Manchester LC, Poeggeler B, Alvarez FL, Ogden GB and Reiter RJ. 1995. Melatonin immunoreactivity in the prokaryote Rhodospirillum rubrum: implications for an ancient antioxidant system. Cell Mol Biol Res 41:391–395.
  • Manda K, Ueno M and Anzai K. 2007. AFMK, a melatonin metabolite, attenuates x-ray induced oxidation damage to DNA, proteins and lipids in mice. J Pineal Res 42:386–393.
  • Manda K, Ueno M and Anzai K. 2008. Melatonin mitigates oxidative damage and apoptosis in mouse cerebellum by high-LET 56Fe particle irradiation. J Pineal Res 44:189–196.
  • Mansouri A, Demeilliers C, Amsellem S, Pessayre D and Fromenty B. 2001. Acute ethanol administration oxidatively damages and depletes mitochondrial DNA in mouse liver, brain, heart, and skeletal muscle: protective effects of melatonin. J Pharmacol Exp Ther 298:737–743.
  • Markowska M, Bentkowski P, Kloc M and Pijanowska J. 2009. Presence of melatonin in Daphnia magna. J Pineal Res 46:242–243.
  • Marshall KA, Reiter RJ, Poeggeler B, Aruoma OI and Halliwell B. 1996. Evaluation of the antioxidant activity of melatonin in vitro. Free Radic Biol Med 21:307–315.
  • Martin MJ, Macias M, Escames G, Leon J and Acuna-Castroviejo D. 2000a. Melatonin but not vitamins C and E maintains glutathione homeostasis in t-butyl-hydroperoxide-induced mitochondrial oxidative stress. FASEB J 14:1677–1679.
  • Martin MJ, Macias M, Escames G, Reiter RJ, Agapito MP, Ortiz GG and Acuna-Castroviejo D. 2000b. Melatonin induced increased activity of the respiratory chain complexes I and IV can prevent mitochondrial damage induced by ruthenium red in vivo. J Pineal Res 28:193–248.
  • Martinez-Cruz F, Pozo D, Osuna C, Espinar A, Merchante C and Guerrero JM. 2002. Oxidative stress induced by phenylketonuria in the rat: prevention by melatonin, vitamin E and vitamin C. J Neurosci Res 69:550–558.
  • Martinez-Cruz F, Osuna C and Guerrero JM. 2006. Mitochondrial damage induced by fetal hyperphenylalaninemia in the rat brain and liver: its prevention by melatonin, vitamin E and vitamin C. Neurosci Lett 392:1–4.
  • Masson-Pevet M. 2007. Melatonin in the circadian system (in French). J Soc Biol 201:77–83.
  • Matuszak Z, Reszka K and Chignell CF. 1997. Reaction of melatonin and related indoles with hydroxyl radicals: EPR and spin trapping investigations. Free Radic Biol Med 23:367–372.
  • Matuszak Z, Bilska MA, Reszka KJ, Chignell CF and Bilski P. 2003. Interaction of singlet molecular oxygen with melatonin and related indoles. Photochem Photobiol 78:449–455.
  • McCord CP and Allen FB. 1917. Evidence associating pineal gland function with alterations in pigmentation. J Exp Zool 23:207–224.
  • Melchiorri D, Reiter RJ, Attia AM, Hara M, Burgos A and Nistico G. 1994. Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci 56:83–89.
  • Messner M, Huether G, Lorf T, Ramadori G and Schwörer H. 2001. Presence of melatonin in the human hepatobiliary- gastrointestinal tract. Life Sci 69:543–551.
  • Mogler KH. 1958. Das Endokrine System des Syrischen Goldhamster unter Beriicksichtigung des Natürlichen und Experimentellen Winterschlöf. Z Morphol Okeol Tiere 47:267–308.
  • Monobe M, Hino M, Sumi M, Uzawa A, Hirayama R, Ando K, Kojima J. 2005. Protective effects of melatonin on gamma-ray induced intestinal damage. Int J Radiat Biol 81:855–860.
  • Montilla P, Cruz A, Padillo FJ, Tunez I, Gascon F, Munoz MC, Gomez M and Pera C. 2001. Melatonin versus vitamin E as protective treatment against oxidative stress after extra-hepatic bile duct ligation in rats. J Pineal Res 31:138–144.
  • Nesic O, Lee J, Unabia GC, Johnson K, Ye Z, Vergara L, Hulsebosch CE and Perez-Polo JR. 2008. Aquaporin 1 – a novel player in spinal cord injury. J Neurochem 105:628–640.
  • Noda Y, Mori A, Liburty R and Packer L. 1999. Melatonin and its precursor scavenge nitric oxide. J Pineal Res 27:159–163.
  • Okatani Y, Okamoto K, Hayashi K, Wakatsuki A, Tamura S and Sagara V. 1998. Maternal-fetal transfer of melatonin in pregnant women near term. J Pineal Res 25:129–134.
  • Osseni RA, Rat P, Bogdan A, Warnet JM and Touitov Y. 2000. Evidence of a pro-oxidant and antioxidant action of melatonin on human liver cell line HepG2. Life Sci 68:387–399.
  • Pablos MI, Agapito MT, Guiterrez R, Recio JM, Reiter RJ, Barlow-Walden LR, Acuna-Castroviejo D and Menendez-Pelaez A. 1995. Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxidase in several tissues of chicks. J Pineal Res 19:111–115.
  • Pacher P, Beckman JS and Liaudet L. 2007. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87:315–424.
  • Pandi-Perumal SR, Srinivasan V, Maestroni GJ, Cardinali DP, Poeggeler B and Hardeland R. 2006. Melatonin: nature’s most versatile biological signal? FEBS J 273:2813–2838.
  • Pang SF and Allen AE. 1986. Extra-pineal melatonin in the retina: its regulation and physiological function. Pineal Res Rev 4:55–96.
  • Pappolla MA, Chyan YJ, Poeggeler B, Frangione B, Wilson G, Ghiso J and Reiter RJ. 2000. An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer’s disease. J Neural Transm 107:203–231.
  • Paul S, Sharma AV, Mahapatra PD, Bhattacharya M, Reiter RJ and Swarnakar S. 2008. Role of melatonin in regulating matrix metalloproteinase-9 via tissue inhibitors of metalloproteinase-1 during protection against endometriosis. J Pineal Res 44:439–449.
  • Peschke E. 2008. Melatonin, endocrine pancreas and diabetes. J Pineal Res 44:26–40.
  • Peyrot F and Ducrocq C. 2008. Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and reactive nitrogen species. J Pineal Res 45:235–246.
  • Peyrot F, Martin MT, Migault J and Ducrocq C. 2003. Reactivity of peroxynitrite with melatonin as a function of pH and CO2 content. Eur J Org Chem 1:172–181.
  • Pieri C, Marra M, Moroni F, Recchioni R and Marcheselli F. 1994. Melatonin: a peroxyl radical more effective than vitamin E. Life Sci 55:PL271–PL276.
  • Poeggeler B. 2005. Melatonin, aging and age-related diseases: perspectives for prevention, intervention, and therapy. Endocrine 27:201–212.
  • Pozo D, Reiter RJ, Calvo JR and Guerrero JM. 1994. Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life Sci 55:PL455–PL460.
  • Pozo D, Reiter RJ, Calvo JR and Guerrero JM. 1997. Inhibitor of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J Cell Biochem 65:430–442.
  • Qi W, Reiter RJ, Tan DX, Manchester LC, Siu AW and Garcia JJ. 2000a. Increased levels of damaged DNA induced by chromium (III) and H2O2: protection by melatonin and related molecules. J Pineal Res 29:54–61.
  • Qi W, Reiter RJ, Tan DX, Garcia JJ, Manchester LC, Karbownik M and Calvo JR. 2000b. Chromium (III)-induced 8- hydroxydeoxyguanosine in DNA and its reduction by antioxidants: comparative efforts of melatonin, ascorbate and vitamin E. Environ Health Perspect 108:399–402.
  • Qi W, Reiter RJ, Tan DX, Manchester LC and Calvo JR. 2001. Melatonin prevents δ-aminolevulinic acid-induced oxidative DNA damage in the presence of Fe2+. Mol Cell Biochem 218:87–92.
  • Quay WB. 1956. Volumetric and cytologic variation in the pineal body of Peromyscus leucopus (Rodentia) with respect to sex, captivity and daylength. J Morphol 98:471–475.
  • Quay WB. 1964. Circadian and estrous rhythms in pineal melatonin and 5-hydroxyindole-3- acetic acid. Proc Soc Exp Biol Med 115:710–713.
  • Reiter RJ. 1973a. Pineal control of a seasonal reproductive rhythm in male golden hamsters exposed to natural daylight and temperature. Endocrinology 92:423–430.
  • Reiter RJ. 1973b. Comparative physiology: pineal gland. Annu Rev Physiol 35:305–328.
  • Reiter RJ. 1974. Circannual reproductive rhythms in mammals related to photoperiod and pineal function. Chronobiologia 1:365–395.
  • Reiter RJ. 1991. Melatonin: the chemical expression of darkness. Mol Cell Endocrinol 79:C153–C158.
  • Reiter RJ. 1995. Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J 9:526–533.
  • Reiter RJ. 1998. Oxidative damage in the central nervous system: protection by melatonin. Progr Neurobiol 56:359–384.
  • Reiter RJ. and Hester RJ. 1966. Interrelationships of the pineal gland, the superior cervical ganglia and the photoperiod in the regulation of the endocrine systems of hamsters. Endocrinology 79:1168–1170.
  • Reiter RJ and Korkmaz A. 2008. Clinical aspects of melatonin. Saudi Med J 29:1537–1547.
  • Reiter RJ and Tan DX. 2003. What constitutes a physiological concentration of melatonin? J Pineal Res 34:79–80.
  • Reiter RJ, Tan DX, Osuna C and Gitto E. 2000. Actions of melatonin in the reduction of oxidative stress: a review. J Biomed Res 7:444–458.
  • Reiter RJ, Tan DX, Manchester LC and Qi W. 2001. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence. Cell Biochem Biophys 34:237–246.
  • Reiter RJ, Tan DX, Manchester LC, Lopez-Burillo S, Sainz RM and Mayo JC. 2003. Melatonin: detoxification of oxygen and nitrogen-based reactants. Adv Exp Med Biol 527:539–548.
  • Reiter RJ, Tan DX and Pappolla MA. 2004. Melatonin relieves the neural oxidative burden that contributes to dementias. Ann NY Acad Sci 1035:179–195.
  • Reiter RJ, Tan DX, Leon J, Kilic U and Kilic E. 2005a. When melatonin gets on your nerves: its beneficial actions in experimental models of stroke. Exp Biol Med 230:104–117.
  • Reiter RJ, Manchester LC and Tan DX. 2005b. Melatonin in walnuts: influence on levels of melatonin and total antioxidant capacity of blood. Nutrition 21:920–924.
  • Reiter RJ, Tan DX and Maldonado MD. 2005c. Melatonin as an antioxidant: physiology versus pharmacology. J Pineal Res 39:215–216.
  • Reiter RJ, Tan DX, Jou MJ, Korkmaz A, Manchester LC and Paredes SD. 2008a. Biogenic amines in the reduction of oxidative stress: melatonin and its metabolites. Neuroendocrinol Lett 29:391–398.
  • Reiter RJ, Paredes S, Korkmaz A, Jou MJ and Tan DX. 2008b. Melatonin combats molecular terrorism at the mitochondrial level. Interdisc Toxicol 1:137–149.
  • Reiter RJ, Paredes SD, Korkmaz A, Manchester LC and Tan DX. 2008c. Melatonin in relation to the “strong” and “weak” versions of the free radical theory of aging. Adv Med Sci 53:1–11.
  • Rodriquez C, Mayo JC, Sainz RM, Antolin I, Herrera F, Martin V and Reiter RJ. 2004. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res 36:1–9.
  • Rosales-Corral S, Tan DX, Reiter RJ, Valdivia-Velazquez M, Martinez-Barboza G, Acosta-Martinez JP and Ortiz GG. 2003. Orally administered melatonin reduces oxidative stress and proinflammatory cytokines induced by amyloid-β peptide in rat brain: a comparative, in vivo study versus vitamin C and E. J Pineal Res 35:80–84.
  • Rosen J, Than NN, Koch D, Poeggeler B, Laatsch H and Hardeland R. 2006. Interactions of melatonin and its metabolites with ABTS cation radical: extension of the radical scavenger cascade and formation of a novel class of oxidation products, C2-substituted 3-indolinones. J Pineal Res 41:374–381.
  • Ross R. 1999. Atherosclerosis – an inflammatory disease. N Engl J Med 340:115–126.
  • Rozov SV, Filatova EV, Orlov AA, Volkova AV, Zhloba ARA, Blashko EL and Pozdeyev NV. 2003. N1-acetyl-N2-formyl-5-methoxykynuramine is a product of melatonin oxidation in rats. J Pineal Res 35:245–250.
  • Sadir S, Deveci S, Korkmaz A and Oter S. 2007. Alpha-tocopherol, beta-carotene and melatonin administration protects cyclophosphamide-induced oxidative damage in bladder tissue of rats. Cell Biochem Funct 25:521–526.
  • Sahna E, Olimez E and Acet A. 2002. Effects of physiological and pharmacological concentrations of melatonin on ischemia-reperfusion arrhythmias in rats: can the incidence of sudden cardiac death be reduced? J Pineal Res 32:194–198.
  • Sahna E, Parkohpinar H, Ozer MK, Ozturk F, Ozugurlu F and Acet A. 2003. Melatonin protects against myocardial doxorubicin toxicity in rats: role of physiologic concentrations. J Pineal Res 35:357–361.
  • Sai K, Takagi A, Umemura T, Hasegawa R and Kurokawa Y. 1991. Relation of 8-hydroxydeoxyguanosine formation in rat kidney to lipid peroxidation, glutathione level and relative organ weight after a single administration of potassium bromate. Jpn J Cancer 82:165–169.
  • Samantaray S, Sribnick EA, Das A, Knaryan VH, Matzelle DD, Yallapragada AV, Reiter RJ, Ray SK and Banik N. 2008. Melatonin attenuates calpain upregulation; axonal damage and neuronal death in spinal cord injury in rats. J Pineal Res 44:348–357.
  • Sener G, Sehirli AO and Ayanoglu-Dulger G. 2003. Protective effect of melatonin, vitamin E and N-acetylcysteine against acetaminophen toxicity in mice: a comparative study. J Pineal Res 35:61–68.
  • Sewerynek E, Melchiorri D, Reiter RJ, Ortiz GG and Lewinski A. 1995a. Lipopolysaccharide-induced hepototoxicity is inhibited by the antioxidant melatonin. Eur J Pharmacol 293:327–334.
  • Sewerynek E, Melchiorri D, Chen L and Reiter RJ. 1995b. Melatonin reduces both basal and bacterial lipopolysaccharide-induced lipid peroxidation in rats. Free Radic Biol Med 19:903–909.
  • Sharma S and Haldar C. 2009. Comparative effect of melatonin and vitamin E on phenylhydrazine-induced toxicity in the spleen of Funambulus pennanti. Environ Toxicol 24:1–9.
  • Shirazi A, Ghobadi G and Ghazi-Khanasari M. 2007. A radiobiological review on melatonin: a novel radioprotecor. J Radiat Res (Tokyo) 48:263–272.
  • Shiu SYW. 2007. Towards rational and evidence-based use of melatonin in prostate cancer prevention and treatment. J Pineal Res 43:1–9.
  • Siddiqi NJ and Pandey VC. 1999. Studies on hepatic oxidative stress and antioxidative defense systems during arteether treatment of Plasmodium yoelii nigeriensis infected mice. Mol Cell Biochem 196:169–173.
  • Silva SO, Ximenes VF, Catalani IH and Campa A. 2000. Myeloperoxidase-catalyzed oxidation of melatonin by activated neutrophils. Biochem Biophys Res Commun 279:657–662.
  • Silva SO, Rodrigues MR, Carvalho SR, Catalani LH, Campo A and Ximenes VF. 2004. Oxidation of melatonin and its catabolites, N1-acetyl-N2-formyl-5-methoxykynuramine and N1-acetyl-5-methoxykynuramine by activated leucocytes. J Pineal Res 37:171–175.
  • Simko F. and Paulis L. 2007. Melatonin as a potent antihypertensive treatment. J Pineal Res 42:319–322.
  • Siu AW, Maldonado MD, Sanchez-Hidalgo M, Tan DX and Reiter RJ. 2006. Potential effects of melatonin in experimental free radical-related ocular diseases. J Pineal Res 40:101–109.
  • Siwicka A, Reiter RJ, Tan DX, Wojtasiewicz KI, Leniewski A, Maurin JK, Blachot D and Czarnocki Z. 2004. The structure of NO-diacetyl derivative of cyclic 3-hydroxymelatonin is unambiguously proven. Centr Eur J Chem 2:425–433.
  • Siwicka A, Moleda Z, Wojtasiewicz K, Zawadzka A, Maurin JK, Panasiewicz M, Pacuszka T and Czarnocki Z. 2008. The oxidation products of melatonin derivatives exhibit acetylcholinesterase and butyrylcholinesterase inhibiting activity. J Pineal Res 45:40–49.
  • Skinner DC and Malpaux B. 1999. High melatonin concentrations in the third ventricular cerebrospinal fluid are not due to Galen vein blood recirculating through the choroid plexus. Endocrinology 14:4399–4405.
  • Slominski A, Baker J, Rosano TG, Guisti LW, Ermak G, Grande M and Gaudet SJ. 1996. Metabolism of serotonin, to N-acetylserotonin, melatonin and 5-methoxytryptamine in hamster skin. J Biol Chem 271:12281–12286.
  • Slominski A, Pisarchik A, Semak I, Sweatman T, Wortsman J, Szczesniewski A, Slugocki G, McNulty J, Kauser S, Tobin DJ, Jing C, and Johansson O. 2002. Serotoninergic and melatoninergic systems are fully expressed in human skin. FASEB J 16:896–898.
  • Slominski A, Tobin DJ, Zmijewski MA, Wortsman J and Paus R. 2007. Melatonin in skin: synthesis, metabolism and functions. Trends Endocrinol Metab 19:17–24.
  • Sofic E, Rimpapa Z, Kundurovic Z, Sapcanin A, Tahirovic I, Rustembegovic A and Gao G. 2005. Antioxidant capacity of the neurohormone melatonin. J Neural Transm 112:349–358.
  • Spector A and Garner WH., 1981. Hydrogen peroxide and human cataract. Exp Eye Res 33:673–681.
  • Starkov AA. 2008. The role of mitochondria in reactive oxygen species metabolism and signaling. Ann NY Acad Sci 1147:37–52.
  • Stasica P, Ulanski P and Rosiak JM. 1998. Melatonin as a hydroxyl radical scavenger. J Pineal Res 25:65–66.
  • Stasica P, Paneth P and Rosiak JM. 2000. Hydroxyl radical reaction with melatonin molecule: a computational study. J Pineal Res 29:125–127.
  • Stefulj J, Hörtner M, Ghosh M, Schavenstein I, Rinner I, Wölfier A, Semmler J and Liebmann PM. 2001. Gene expression of the key enzymes of melatonin synthesis in extrapineal tissues of the rat. J Pineal Res 30:243–247.
  • Tamarkin L, Baird CJ and Almeida OF. 1985. Melatonin: a coordinating signal for mammalian reproduction. Science 227:714–720.
  • Tamura H, Nakamura Y, Terron MP, Flores LJ, Manchester LC, Tan DX, Sugino N and Reiter RJ. 2008a. Melatonin and pregnancy in the human. Reprod Toxicol 25:291–303.
  • Tamura H, Takasaki A, Miwa I, Taniguchi K, Maekawa R, Asada H, Taketani T, Matsuoka A, Yamagata Y, Shimamura L. Morioka H, Ishikawa H, Reiter RJ, and Sugino N. 2008b. Oxidative stress impairs oocyte quality and melatonin protects oocytes from free radical damage and improves fertilization rate. J Pineal Res 44:280–287.
  • Tamura H, Nakamura Y, Korkmaz A, Manchester LC, Tan DX, Sugino N and Reiter RJ. 2009. Melatonin and the ovary: physiology and pathophysiological implications. Fertil Steril, in press.
  • Tan DX, Chen LD, Poeggeler B, Manchester LC and Reiter RJ. 1993. Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocrine J 1:57–60.
  • Tan DX, Reiter RJ and Chen LD. 1994. Both physiological and pharmacological level of melatonin reduce DNA adduct formation induced by the carcinogen safrole. Carcinogenesis 15: 215–218.
  • Tan DX, Manchester LC, Reiter RJ, Plummer BF, Hardies LJ, Weintraub ST, Vijayalaxmi and Shepherd AMM. 1998a. A novel melatonin metabolite, cyclic 3-hydroxymelatonin, and biomarker of in vivo hydroxyl radical generation. Biochem Biophys Res Commun 253:614–620.
  • Tan DX, Manchester LC, Reiter RJ, Qi W, Kim SJ and El-Sokkary GH. 1998b. Ischemia/reperfusion-induced arrhythmias in isolated rat heart: prevention my melatonin. J Pineal Res 25:184–191.
  • Tan DX, Manchester LC, Reiter RJ, Qi W, Hanes MA and Farley NJ. 1999a. High physiological levels of melatonin in the bile of mammals. Life Sci 65:2523–2529.
  • Tan DX, Manchester LC, Reiter RJ, Qi W, Zhang M, Weintraub ST, Cabrera J, Sainz RM and Mayo JC. 1999b. Identification of highly elevated levels of melatonin in bone marrow: its origin and significance. Biochem Biophys Acta 1472:206–214.
  • Tan DX, Manchester CC, Reiter RJ, Plummer BF, Limson J, Weintraub ST and Qi W. 2000. Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radic Biol Med 29:177–1185.
  • Tan DX, Reiter RJ, Manchester LC, Yan MT, El-Sawi M, Sainz RM, Mayo JC, Cohen R, Allegra M and Hardeland R. 2002. Chemical and physical properties and potential mechanisms: melatonin as a broad spectrum antioxidant and free radical scavenger. Curr Top Med Chem 2:181–197.
  • Tan DX, Hardeland R, Manchester LC, Poeggeler B, Lopez-Burillo S, Mayo JC, Sainz RM and Reiter RJ. 2003. Mechanistic and comparative studies of melatonin and classic antioxidants in terms of their interactions with ABTS cation radical. J Pineal Res 34:249–259.
  • Tan DX, Manchester LC, Terron MP, Flores LJ and Reiter RJ. 2007a. One molecule, many derivatives: a never-ending interaction of melatonin with reactive oxygen and nitrogen species. J Pineal Res 42:28–42.
  • Tan DX, Manchester LC, Di Mascio P, Martinez GR, Prado FM and Reiter RJ. 2007b. Novel rhythms of N1-acetyl-N2-formyl-5-methoxykynuramine and its precursor melatonin in water hyacinth: importance in phytoremediation. FASEB J 21:1724–1729.
  • Tan DX, Manchester LC, Helton P and Reiter RJ. 2007c. Phytoremediative capacity of plants enriched with melatonin. Plant Sign Behav 2:514–516.
  • Tengattini S, Reiter RJ, Tan DX, Terron MP, Rodella LF and Rezzani R. 2008. Cardiovascular disease: protective effects of melatonin. J Pineal Res 44:16–25.
  • Tesoriere L, Avellone G, Ceraulo L, D’Arpa D, Allegra M and Livrea MA. 2001. Oxidation of melatonin by oxoferryl hemoglobin: a mechanistic study. Free Radic Res 35:633–642.
  • Than NN, Heer C, Laatsch H and Hardeland R. 2006. Reactions of the melatonin metabolite, N1-acetyl-5-methoxykynuramine (AMK) with the ABTS cation radical: identification of new oxidation products. Redox Rep 11:15–24.
  • Thieblot L and Le Bars H. 1955. Le Glande Pineole an Epiphyes. Paris: Maloine.
  • Tilden AR, Becker MA, Amma LL, Arcinceger J and McGaw AK. 1997. Melatonin production in an aerobic photosynthetic bacterium: an evolutionary early association with darkness. J Pineal Res 22:102–106.
  • Tomas-Zapico C and Coto-Montes A. 2005. A proposed mechanism to explain the stimulatory effect of melatonin on antioxidative enzymes. J Pineal Res 39:99–104.
  • Topal T, Oztas Y, Korkmaz A, Sadir S, Oter S, Coskun O and Bilgic H. 2005. Melatonin ameliorates bladder damage induced by cyclophosphamide in rats. J Pineal Res 38:272–277.
  • Troiani ME, Reiter RJ, Vaughan MK, Oakin S and Vaughan GM. 1988a. Swimming depresses nighttime melatonin content without changing N-acetyltransferase activity in the rat pineal gland. Neuroendocrinology 47:55–60.
  • Troiani ME, Reiter RJ, Tannenbaum MG, Puig-Domingo M, Guerrero JM and Menendez-Pelaez A. 1988b. Neither the pituitary nor the sympathetic nervous system is responsible for eliciting the large drop in elevated rat pineal melatonin levels due to swimming. J Neurol Transm 74:14–460.
  • Tunez I, Munoz MC, Medina FJ, Salcedo M, Feijoo M and Montilla P. 2007. Comparison of melatonin, vitamin E and L-carnitine in the treatment of neuro- and hepatotoxicity induced by thioacetamide. Cell Biochem Funct 25:119–127.
  • Turjanski AG, Rosenstein RE and Estrin DA. 1998. Reactions of melatonin and related indoles with free radicals: a computational study. J Med Chem 41:3684–3689.
  • Turjanski AG, Saenz DA, Doctorovich F, Estrin DA and Rosenstein RE. 2001. Nitrosation of melatonin by nitric oxide: a computational study. J Pineal Res 33:31–36.
  • Urata Y, Honma S, Goto S, Todoroki S, Iida T, Cho S, Honma K and Kondo T. 1999. Melatonin induces gamma-glutamyl cysteine synthase mediated by activator protein-1 in human vascular endothelial cells. Free Rad Biol Med 27:838–847.
  • Valeyrie-Allanore I, Poulalhon W, Fagot JP, Sekula P, Anidovici B, Sidorff A, Mockenhaupt M. 2008. Stevens-Johnson syndrome and toxic experimental necrolysis induced by amifostine during head and neck radiotherapy. Radiother Oncol 87:300–303.
  • Velkov ZA, Velkov YZh, Galunska BT, Paskalev DN and Todjer AV. 2009. Melatonin: quantum-chemical and biochemical investigation of antioxidant activity. Eur J Med Chem, 44: 2834–2839.
  • Vijayalaxmi, Reiter RJ and Meltz ML. 1995a. Melatonin protects human blood lymphocytes from radiation induced chromosome damage. Mutat Res 346:23–31.
  • Vijayalaxmi, Reiter RJ, Sewerynek E, Poeggeler B, Leal BZ and Meltz JL. 1995b. Marked reduction in radiation-induced micronuclei in human blood lymphocytes pretreated with melatonin. Radiat Res 43:102–106.
  • Vijayalaxmi, Reiter RJ, Leal BZ and Meltz ML. 1996a. Effect of melatonin on mitotic and proliferative indices, and sister chromatid exchange in human blood lymphocytes. Mutat Res 351:187–192.
  • Vijayalaxmi, Reiter RJ and Meltz ML. 1996b. Melatonin and radioprotection from genetic damage: in vivo/in vitro studies with human volunteers. Mutat Res 371 221–228.
  • Vijayalaxmi, Reiter RJ, Herman TS and Meltz ML. 1996c. Melatonin and radioprotection from genetic damage: in vivo/in vitro studies with cells from human volunteers. Mutat Res 371:221–228.
  • Vijayalaxmi, Meltz ML, Reiter RJ and Herman TS. 1999a. Melatonin and protection from genetic damage in blood and bone marrow: whole body radiation studies in mice. J Pineal Res 27:221–225.
  • Vijayalaxmi, Meltz ML, Reiter RJ, Herman TS and Kumar S. 1999b. Melatonin and protection from whole body radiation: survival studies in mice. Mutat Res 425:21–27.
  • Vijayalaxmi, Meltz ML, Reiter RJ and Herman TS. 1999c. Melatonin and protection from genetic damage in blood and bone marrow: whole-body irradiation studies in mice. J Pineal Res 27:221–225.
  • Vijayalaxmi, Reiter RJ, Tan DX, Herman TS and Thomas Jr CR. 2004. Melatonin as a radioprotective agent: a review. Int J Radiat Oncol Biol Phys 59:639–653.
  • Vivien-Roels B and Pevet P. 1993. Melatonin, presence and formation in invertebrates. Experientia 49:642–647.
  • Wakatsuki A, Okatani Y, Shinohara K, Ikenoue N and Fukaya T. 2001. Melatonin protects against ischemia/reperfusion induced oxidative damage to mitochondria in fetal rat brain. J Pineal Res 31:167–172.
  • Weaver DR. 1997. Reproductive safety of melatonin: a “wonder drug” to wonder about. J Biol Rhythms 12:682–689.
  • Weisenberg I, Missbach M, Kahlen JP, Schrader M and Carlberg C. 1995. Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification CGP 52608 as a synthetic ligand. Nucleic Acids Res 23:327–333.
  • Weishaupt JH, Bartels C, Polking E, Dietrich J, Rhode G, Poeggeler B, Mertens N, Sperling S, Bohn M, Huether G, Schneider A, Bach A, Siren AL, Hardeland R, Bahr M, Navek A, and Ehrenreich H. 2006. Reduced oxidative damage in ALS by high-dose enteral melatonin treatment. J Pineal Res 41:313–323.
  • Welin AK, Svedin P, La Patto R, Sultan R, Hagberg H, Gressens P, Kjellmer I and Mallard C. 2007. Melatonin reduces inflammation and cell death in white matter in the midgestation fetal sheep following umbilical cord occlusion. Pediatr Res 61:153–158.
  • Whiteman M, Dogra Y, Winyard PG and Armstrong JS. 2008. Detection and measurement of reactive oxygen intermediates in mitochondria and cells. Meth Mol Biol 476:29–50.
  • Winiarska K, Fraczyk T, Malinska D, Drozak J and Bryla J. 2006. Melatonin attenuates diabetes-induced oxidative stress in rabbits. J Pineal Res 40:168–176.
  • Winston GW, Regoli F, Dugas Jr AJ, Fong JH and Blanchard KA. 1998. A rapid gas chromatographic assay for determining oxyradical scavenging activity of antioxidants and biological fluids. Free Radic Biol Med 24:480–493.
  • Wolfler A, Caluba HC, Abuja PM, Pohr G, Schauenstein K and Liebmann PM. 2001. Prooxidant activity of melatonin promotes fas-induced cell death in human leukemic Jurkat cells. FEBS Lett 502:127–131.
  • Wu WT, Reiter RJ, Troiani ME and Vaughan GM. 1987. Elevated daytime rat pineal and serum melatonin levels induced by isoproterenol are depressed by swimming. Life Sci 41:1473–1479.
  • Wu WT, Chen YC and Reiter RJ. 1988. Day-night differences in the response of the pineal gland to swimming stress. Proc Soc Exp Biol Med 187:315–319.
  • Ximenes VF, Catalini LH and Campa IH. 2001. Oxidation of melatonin and tryptophan by an HRP cycle involving compound III. Biochem. Biophys Res Commun 287:130–134.
  • Yilmaz S and Yilmaz E. 2006. Effects of melatonin and vitamin E in oxidative-antioxidative status in rats exposed to irradiation. Toxicology 222:1–7.
  • Yilmaz T, Celebi S and Kukner AS. 2002. The protective effects of melatonin, vitamin E and octreotide on retinal edema during ischemia-reperfusion in the guinea pig. Eur J Ophthalmol 12:443–449.
  • Yin J, Liu YH, Xu YF, Zhang YJ, Chen JG, Shu BH and Wang JZ. 2006. Melatonin arrests peroxynitrite-induced tau hyperphosphorylation and the over activation of protein kinases in rat brain. J Pineal Res 42:124–129.
  • Zavodnik IB, Domanski AV, Lapshina EA, Bryzewska M and Reiter RJ. 2006. Melatonin directly scavenges free radicals generated in red blood cells and a cell-free system: chemiluminescence measurements and theoretical calculations. Life Sci 79:391–400.
  • Zhang H, Squadrito GL and Pryor WA. 1998. The reaction of melatonin with peroxynitrite: formation of melatonin radical cation and absence of stable nitrated products. Biochem Biophys Res Commun 251:83–87.
  • Zhang H, Squadrito GL, Uppu R and Pryor WA. 1999. Reaction of peroxynitrite with melatonin: a mechanistic study. Chem Res Toxicol 12:526–534.
  • Zupancic D, Jezernik K and Vidmar G. 2008. Effect of melatonin apoptosis, proliferation and differentiation of urothelial cells after cyclophosphamide treatment. J Pineal Res 44:299–306.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.